Antibodies Against Sars-cov And Methods Of Use Thereof

Abstract

The invention provides scFv antibodies and monoclonal antibodies that neutralize SARS-CoV. Also provided are methods of treating and/or preventing a coronavirus-related disease or disorder such as SARS. The invention also provides methods of vaccinating a patient against SARS-CoV. Also provided are methods of diagnosing coronavirus-related diseases or disorders and methods of detecting the presence of a coronavirus in a sample. The invention additionally provides methods of screening for compounds that modulate the binding of SARS-CoV and the SARS-CoV receptor ACE2 as well as for compounds useful to treat SARS-CoV-related diseases or disorders.


Claims
Download PDF
Document Preview
Document History
  • Publication: Jul 6, 2010
  • Application: Nov 24, 2004
    US US 99720104 A
  • Priority: Nov 24, 2004
    US US 99720104 A
  • Priority: Nov 25, 2003
    US US 52484003 P

Download Citation


Sign in to the Lens

Feedback